Nexalin Technology, Inc. (NXL) analyst actions
Rating and price-target actions on NXL in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NXL overview →
2 measured NXL analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback | Press release | +5.83% | +1.03% | |
| Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval | Press release | -4.91% | -1.46% |
Keep exploring
More NXL: earnings → · SEC filings → · NXL overview →